Real-time enrollment status for this atopic dermatitis clinical trial
Current Status
Recruiting
Checked: October 20, 2026 at 6:46 PM UTC
| NCT Number | NCT07765888 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis |
| Phase | PHASE3 |
| Target Enrollment | 375 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | October 15, 2026 (5 days ago) |
As of October 20, 2026: Clinical trial NCT07765888 is currently recruiting participants. This phase3 study for atopic dermatitis is actively seeking new participants at 14 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07765888 is actively recruiting participants as of October 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07765888 was last updated 5 days ago (October 15, 2026). HelloStudys verifies this status automatically.